Merck recalls Vioxx after heart risks rise
Merck & Co pulls its arthritis drug Vioxx from the market amid data showing double the risk of heart attacks and strokes after 18 months of use. The recall shocks the stock, impacts global users, and prompts doctors to switch patients to Celebrex, Bextra, or older anti inflammatories.
MENTIONED IN THIS ARTICLE
Trenton
Merck & Co
Merck’s
Merck
Donald Loveman
Texas Tech University Health Sciences Center
Odessa
Loveman
El Paso Corp posts $1.93 billion loss for 2003
El Paso Corp reports a 2003 loss of 1.93 billion and restates 2001 and 2002 results. The SEC filing notes a division was subpoenaed by a New York grand jury for Oil for Food records. Shares rose 49 cents to 9.19 on the NYSE.
MENTIONED IN THIS ARTICLE
el Paso Corp
Houston
Securities and Exchange Commission
New York
United Nations
el Paso
SEC
el Paso Cgp Co
The
Coastal Corp
Iraq
New York Grand Jury
Congressional
New York Stock Exchange
Kim Wallace
Enron Corp
Duke Energy
Williams Cos
Also Mentioned on This Page
Sarre
4Th Street
Charlotta Holbert
Lee le Seal Rae
Alomusa
Wwil
Jimmy Franklin
Kent Shockley
Jim LeRoy
Jan Collmer
FINA
Julie Clark
U.S. Army
Golden Knights
Airsho.org
Bebt' Ak
Rypele Eying
Peacename
Midland
America
Andrews
Texas
China Hutch
Monthlu
Habla Espanol
Hooker